-transparent.png){kind=logo}
The penetration of cefmenoxime, a newly-developed cephalosporin, across non-inflamed meninges was studied in 12 volunteers undergoing elective myelograms. Patients received 30 mg/kg of cefmenoxime intravenously every 6 h for three doses. Trough and peak serum levels were drawn just prior to and immediately after the last dose. CSF was obtained from 1 to 4 h after the administration of the last dose and a concomitant serum sample was also drawn. Cefmenoxime levels were determined by a microbiological assay and by high-performance liquid chromatography (HPLC). Cefmenoxime was detected in the CSF of all 12 patients and ranged between 0.15 and 1.4 mg/l.
Related Publications
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
January 1987,
Infection,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
March 1980,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
November 1993,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
June 1991,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
July 1990,
Neurochirurgia,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
July 1994,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
April 1992,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
November 1984,
Antimicrobial agents and chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
January 2000,
Antimicrobial agents and chemotherapy,
K V Rolston, and
P H Chandrasekar, and
B R Smith, and
J L LeFrock
September 1986,
Antimicrobial agents and chemotherapy,
